| VYNE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VYNE shares outstanding history going back to 7/30/2020:
Also see: VYNE Market Cap History VYNE YTD Return |
As of 2/12/2026 VYNE Therapeutics has 33.32 million VYNE shares outstanding. Investors often track the VYNE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows VYNE share count trends over time, with 25 historical shares outstanding datapoints presented, dating back to 7/30/2020.

| VYNE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VYNE shares outstanding history going back to 7/30/2020:
Also see: VYNE Market Cap History VYNE YTD Return |
| VYNE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
VYNE Historical Shares Outstanding: +61.62% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| VYNE Stock Price Chart |
| About VYNE Therapeutics Inc |
| VYNE Therapeutics Inc. is a biopharmaceutical company. Co. is focused on developing differentiated therapies for the treatment of immuno-inflammatory conditions. Its product candidate is VYN201, a locally administered pan-BET inhibitor designed as a soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways while providing low systemic exposure. Its second program is VYN202, a BD2-selective oral small molecule bromodomain and extra-terminal (BET) inhibitor in preclinical development for the treatment of immuno-inflammatory indications. We show 25 historical shares outstanding datapoints in our coverage of VYNE's shares outstanding history. Understanding the changing numbers of VYNE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VYNE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VYNE by allowing them to research VYNE shares outstanding history as well as any other stock in our coverage universe. |
| VYNE Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| VYNE Share Performance |
| Shares Outstanding Peers |
| VYNE Therapeutics (VYNE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
VYNT Shares Outstanding History WAT Shares Outstanding History WCG Shares Outstanding History WGS Shares Outstanding History WHWK Shares Outstanding History WINT Shares Outstanding History WMGI Shares Outstanding History WST Shares Outstanding History XAIR Shares Outstanding History XBIO Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.